Industry

GUANGZHOU, China–(BUSINESS WIRE)–#ADC–Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical study evaluating BAT8006, an antibody drug conjugate (ADC) that targets folic acid receptor α (FRα). The clinical trial is a multicenter, open-label Phase 1 clinical study in patients with advanced solid tumors to … [Read more…]

Series Spotlights the RenovoRx Journey, its Leadership and Innovative Treatment Platform Targeting Difficult-to-Treat Cancers LOS ALTOS, Calif.–(BUSINESS WIRE)–RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced the launch of a new video series – The RenovoRx Story. This video series provides viewers with a unique … [Read more…]

MINNEAPOLIS–(BUSINESS WIRE)–Flywheel, the leading data management platform for biomedical research and collaboration, is adding two new solutions to its product suite. The tools will give researchers new ways to streamline clinical trials, plus discover patient cohorts and analyze data on an enterprise scale. Flywheel Trial Flow is Flywheel’s data management platform for compliant clinical data … [Read more…]

SaaS Veteran to Lead Marketing Efforts for All-in-One Solution for Independent Practices NEWPORT BEACH, Calif.–(BUSINESS WIRE)–#EHR—Tebra, the digital backbone for independent healthcare practices, announced that Kevin Marasco has joined the company as Chief Marketing Officer. Kevin will lead the marketing team and report directly to CEO Dan Rodrigues. As CMO, he will lead all aspects … [Read more…]

Premium heart rate strap will now track pace and distance during indoor runs, giving athletes even more data to push their limits OLATHE, Kan.–(BUSINESS WIRE)–Garmin® International, Inc., a unit of Garmin Ltd. (NYSE: GRMN), today announced the HRM-Pro™ Plus, a premium heart rate strap that adds pace and distance data while continuing to provide athletes … [Read more…]

Webcast of Capital Markets Day on August 3 will include discussion of fiscal fourth-quarter results ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will release fourth-quarter results the evening of August 2. In lieu of hosting a quarterly earnings conference call, CSI management will discuss fourth-quarter results at the beginning of its capital markets … [Read more…]

Conference Call and Webcast Scheduled for 1:30 p.m. PT ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release second quarter 2022 financial results after the market close on Wednesday, August 3, 2022. The … [Read more…]

LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, and LimaCorporate S.p.A., a global orthopedic company focused on digital innovation and patient-tailored hardware, today announced a licensing partnership for the U.S. market to provide a novel solution for patients with the challenging condition of chronic high dislocation … [Read more…]

Orion to receive an upfront payment of USD 290 million Agreement strengthens and complements Merck’s oncology pipeline RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Orion Corporation (“Orion”) today announced a global development and commercialization agreement for Orion’s investigational candidate ODM-208 and other drugs targeting cytochrome P450 … [Read more…]

Phase 3 trial demonstrated a reduction in SARS-CoV-2 viral load in high-risk COVID-19 patients by 94% and 99% within 24 and 48 hours of treatment, respectively Median time to a negative PCR test was three days after beginning treatment in the nitric oxide group vs. seven days in the placebo group (P < 0.05) Participants … [Read more…]